BIIB021, an Hsp90 inhibitor, effectively kills a myelodysplastic syndrome cell line via the activation of caspases and inhibition of PI3K/Akt and NFκB pathway proteins

Author:            

Publisher: Spandidos Publications

ISSN: 1792-0981

Source: Experimental and Therapeutic Medicine, Vol.7, Iss.6, 2014-01, pp. : 1539-1544

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content